Israel: Teva upsizes and prices SLNs to fund bond tender

Teva Pharmaceutical Industries has upsized its planned US$2.06bn offering of sustainability linked notes (SLN) and priced approximately US$2.49bn (equivalent) of senior notes as part of a debt tender offer. The maximum tender was also increased from US$2.25bn to US$2.5bn. The issuance consists of: €800m of 7.375% notes maturing 2029 €500m of 7.875% notes maturing in…

You must be a HMI Subscriber to view this content.

Subscribe Now »